WuXi Biologics Executive and Leadership Team

Jimmy Li, the Chief Executive Officer at WuXi Biologics, directs the overarching corporate strategy for the integrated technology platforms. Overseeing global expansion, the Chief Executive Officer ensures the organization maintains a competitive edge in the biologics drug development sector. This leadership role involves constant engagement with the Board to align operational goals with long-term market growth. By fostering innovation across all service lines, Jimmy Li drives the company toward achieving excellence in complex molecule manufacturing. The Chief Executive Officer manages the alignment of internal resources to support international client needs, ensuring that the firm remains a preferred partner for pharmaceutical companies worldwide. Through rigorous oversight of corporate governance and strategic partnerships, the Chief Executive Officer secures the financial health and operational stability of the entire enterprise, ultimately positioning the firm as a leader in the global biotechnology landscape.

Ming Tu, the Chief Financial Officer at WuXi Biologics, manages the fiscal health and capital allocation strategies for the integrated technology platforms. Overseeing financial reporting and investor relations, the Chief Financial Officer ensures transparency and accuracy in all corporate disclosures. This leadership role involves optimizing the cost structure of biologics drug development services to maximize shareholder value. By implementing robust financial controls, Ming Tu supports the sustainable growth of the organization across diverse international markets. The Chief Financial Officer collaborates with the executive team to evaluate investment opportunities in new manufacturing facilities and research capabilities. Through precise management of liquidity and risk, the Chief Financial Officer maintains the capital strength necessary for continuous innovation. Ultimately, the Chief Financial Officer provides the fiscal foundation required for the company to scale operations and meet the increasing demand for high-quality biologics development services.

Jijie Gu, the Chief Scientific Officer, President of Global Biologics Research at WuXi Biologics, directs the scientific vision and research initiatives for the integrated technology platforms. Overseeing the discovery and development of novel biologics, the Chief Scientific Officer, President of Global Biologics Research ensures the company delivers high-impact solutions for complex drug development challenges. This leadership role involves managing large-scale research teams to push the boundaries of molecular engineering and therapeutic innovation. By fostering a culture of scientific excellence, Jijie Gu drives the development of proprietary technologies that accelerate the path from target identification to clinical trials. The Chief Scientific Officer, President of Global Biologics Research collaborates with global partners to address unmet medical needs through advanced research methodologies. Through the rigorous application of scientific expertise, the Chief Scientific Officer, President of Global Biologics Research maintains the company's reputation for technical leadership and innovation in the global biotechnology sector.

Xiaohui Liu, the Chief Human Resources Officer & Executive Vice President at WuXi Biologics, directs the talent acquisition and organizational development strategies for the integrated technology platforms. Overseeing the recruitment of top-tier scientific and technical personnel, the Chief Human Resources Officer & Executive Vice President ensures the company maintains a workforce capable of complex biologics drug development. This leadership role involves designing comprehensive training programs to foster internal expertise and innovation. By cultivating a high-performance culture, Xiaohui Liu drives employee engagement and retention across global operations. The Chief Human Resources Officer & Executive Vice President collaborates with department heads to align human capital with the evolving needs of the pharmaceutical industry. Through the implementation of strategic workforce planning, the Chief Human Resources Officer & Executive Vice President supports the company's mission to accelerate drug discovery and manufacturing, ensuring that the organization possesses the necessary human capital to sustain long-term growth.

Sherry Gu, the Executive Vice President & Chief Technology Officer at WuXi Biologics, architects the technical infrastructure and digital transformation strategies for the integrated technology platforms. Overseeing the implementation of advanced manufacturing technologies, the Executive Vice President & Chief Technology Officer ensures the company remains at the forefront of biologics drug development. This leadership role involves integrating cutting-edge automation and data analytics into the development lifecycle to enhance efficiency. By driving technological innovation, Sherry Gu supports the rapid scaling of client projects from discovery to commercial production. The Executive Vice President & Chief Technology Officer collaborates with research teams to refine proprietary platforms, ensuring superior quality and speed in service delivery. Through the continuous modernization of technical systems, the Executive Vice President & Chief Technology Officer enables the firm to address complex manufacturing challenges, ultimately securing the company's position as a premier provider of end-to-end biologics solutions.